logo-loader
viewDeepMatter Group PLC

DeepMatter Group helping to make drugs 'faster, cheaper and more cost effectively'

DeepMatter Group PLC's (LON:DMTR) Mark Warne introduces the business to Proactive London's Andrew Scott and talks through the firm's interim results to June 2019.

''What we're trying to do is address a $28bn problem to improve re-produceability in science so ultimately drugs can be made faster, cheaper and more cost-effectively'' 

''The business was spun out of the University of Glasgow at the back end of 2014, we've grown our Deepmatter platform over the last two or three years .... and now we're generating our first revenues''. 

Quick facts: DeepMatter Group PLC

Price: 2.45 GBX

AIM:DMTR
Market: AIM
Market Cap: £18.05 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Amundi Physical Gold ETC: Europe's cheapest ETC now trading on the London...

Amundi Physical Gold ETC's Ashley Fagan who's head of ETF, Indexing & Smart Beta Development for UK and Ireland introduces the product to Proactive London's Andrew Scott. She says they've seen a great deal of demand from European as well as UK investors and that's what lead them to list...

17 hours, 37 minutes ago

2 min read